Clinical Cancer Drugs

Editor-in-Chief

Giulio Francia
Department of Biological Sciences
The University of Texas
El Paso, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 2, October 2018



Editorial: “Strategies and Methods to Prevent Fluoropyrimidine-associated Toxicities” free to download

Volume:4   Issue: 2
Pp: 73-73
Antonello Di Paolo
DOI: 10.2174/2212697X0402180109161012
Published on: 09 January, 2018



Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 1 – Where Do We Stand?

Volume:4   Issue: 2
Pp: 74-81
Manon Launay, Joseph Ciccolini*, Anne Rodallec, Claire Fournel, Florence Duffaud, Sebastien Salas and Bruno Lacarelle
DOI: 10.2174/2212697X04666170531080625
Published on: 30 May, 2017




Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World

Volume:4   Issue: 2
Pp: 82-92
Antonello Di Paolo*, Marzia Del Re, Elena Arrigoni, Teresa Di Desidero, Eleonora Rofi, Romano Danesi and Guido Bocci
DOI: 10.2174/2212697X04666170817124625
Published on: 17 August, 2017




Fluoropyrimidine-associated Toxicities in Colorectal Cancer Patients: The Epigenetic Point of View

Volume:4   Issue: 2
Pp: 93-103
Laura Bertolaso* and Milena Gusella
DOI: 10.2174/2212697X04999171106143135
Published on: 03 November, 2017




Dermatological, Cardiovascular and Neurological Morphohistopathological Effects of Fluoropyrimidine-based Chemotherapy in Humans

Volume:4   Issue: 2
Pp: 104-111
Gianfranco Natale*, Antonello Di Paolo and Guido Bocci
DOI: 10.2174/2212697X04666171110190256
Published on: 10 November, 2017




Prevention of Capecitabine Toxicity Using a 5-FU Test Dose

Volume:4   Issue: 2
Pp: 112-121
Teresa Di Desidero, Cecilia Barbara, Paola Orlandi, Anna Fioravanti, Fotios Loupakis, Chiara Cremolini, Giacomo Allegrini, Antonello Di Paolo, Alfredo Falcone, Romano Danesi and Guido Bocci*
DOI: 10.2174/2212697X04666170504144550
Published on: 04 May, 2017




Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients

Volume:4   Issue: 2
Pp: 122-128
Manon Launay, Joseph Ciccolini*, Claire Fournel, Carmello Blanquicett, Charlotte Dupuis, Nicolas Fakhry, Florence Duffaud, Sebastien Salas and Bruno Lacarelle
DOI: 10.2174/2212697X04666170817123425
Published on: 17 August, 2017




Progress and Obstacles in the Application of Precision Medicine in the Management of Hepatocellular Carcinoma

Volume:4   Issue: 2
Pp: 129-134
Ping Wang and Xueying Sun*
DOI: 10.2174/2212697X04666170817125451
Published on: 17 August, 2017




Intra-arterial Temozolomide, Osmotic Blood-brain Barrier Disruption and Radiotherapy in a Rat F98-Glioma Model

Volume:4   Issue: 2
Pp: 135-144
Annie I. Drapeau, Marie-Belle Poirier, Guru-Swamy Madugundu, J. Richard Wagner and David Fortin*
DOI: 10.2174/2212697X04666170727152212
Published on: 27 July, 2017




Salvage Hypofractionated Radiotherapy in Combination with Bevacizumab in Patients with Recurrent High Grade Glioma: A Mono-institutional Experience

Volume:4   Issue: 2
Pp: 145-149
Francesco Pasqualetti*, Durim Delishaj, Alessandra Gonnelli, Alessandro Molinari, Martina Cantarella, Stefano Ursino, Maria Grazia Fabrini, Mirco Cosottini and Fabiola Paiar
DOI: 10.2174/2212697X04666171002153516
Published on: 02 October, 2017




Book Review: Handbook of Melanoma Edited by Jonathan S. Zager, Vernon K. Sondak, and Ragini Kudchadkar

Volume:4   Issue: 2
Pp: 150-150
Feng Liang
DOI: 10.2174/2212697X0402180109171607
Published on: 09 January, 2018



Acknowledgements to Reviewers free to download

Volume:4   Issue: 2
Pp: 151-151

DOI: 10.2174/2212697X0402180109171805
Published on: 09 January, 2018